Skip to main content

93 5513 93 5513 (Carbamazepine Extended-Release 200 mg)

Pill with imprint 93 5513 93 5513 is Green / Gray, Capsule-shape and has been identified as Carbamazepine Extended-Release 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Carbamazepine is used in the treatment of trigeminal neuralgia; schizoaffective disorder; bipolar disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 5513 93 5513

Carbamazepine Extended-Release

Imprint
93 5513 93 5513
Strength
200 mg
Color
Green / Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Dibenzazepine anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5513 (Discontinued)
Inactive Ingredients
carnauba wax, D&C Yellow No. 10, aluminum oxide, FD&C Green No. 3, gelatin, ferrosoferric oxide, lactose monohydrate, polyethylene glycol 1450, polyethylene glycol (PEG) 4500, propylene glycol, shellac, sodium lauryl sulfate, sorbitan monolaurate, titanium dioxide, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.